Caribou Biosciences Files 8-K/A Amendment
Ticker: CRBU · Form: 8-K/A · Filed: Sep 27, 2024 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | 8-K/A |
| Filed Date | Sep 27, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, filing-amendment
Related Tickers: CRBU
TL;DR
Caribou Biosciences filed an 8-K/A amendment covering director/officer changes and compensation, plus financials.
AI Summary
Caribou Biosciences, Inc. filed an 8-K/A amendment on September 27, 2024, related to events occurring on September 1, 2024. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This amendment to a previous filing provides updated information regarding corporate governance and executive compensation, which can impact investor confidence and company strategy.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings, especially those concerning executive and director changes, can indicate internal shifts that may affect company direction and performance.
Key Players & Entities
- Caribou Biosciences, Inc. (company) — Registrant
- September 1, 2024 (date) — Earliest event reported date
- September 27, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific events are detailed in the 8-K/A filing by Caribou Biosciences?
The 8-K/A filing details the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
When was the earliest event reported in this 8-K/A filing?
The earliest event reported in this 8-K/A filing occurred on September 1, 2024.
What is the filing date of this 8-K/A amendment?
This 8-K/A amendment was filed on September 27, 2024.
What is the principal executive office address for Caribou Biosciences?
The principal executive office address for Caribou Biosciences is 2929 7th Street, Suite 105, Berkeley, California 94710.
What is the SIC code for Caribou Biosciences?
The Standard Industrial Classification (SIC) code for Caribou Biosciences is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 749 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2024-09-27 16:02:35
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share CRBU NASDAQ Global
Filing Documents
- crbu-20240901.htm (8-K/A) — 27KB
- 0001619856-24-000074.txt ( ) — 155KB
- crbu-20240901.xsd (EX-101.SCH) — 2KB
- crbu-20240901_lab.xml (EX-101.LAB) — 23KB
- crbu-20240901_pre.xml (EX-101.PRE) — 13KB
- crbu-20240901_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Caribou Biosciences, Inc. Date: September 27, 2024 By: /s/ Rachel E. Haurwitz Rachel E. Haurwitz President and Chief Executive Officer